scholarly journals Pain Reduction in Myofascial Pain Syndrome by Anodal Transcranial Direct Current Stimulation Combined With Standard Treatment

2014 ◽  
Vol 30 (12) ◽  
pp. 1076-1083 ◽  
Author(s):  
Piyaraid Sakrajai ◽  
Taweesak Janyacharoen ◽  
Mark P. Jensen ◽  
Kittisak Sawanyawisuth ◽  
Narong Auvichayapat ◽  
...  
Keyword(s):  
Direct Current ◽  
Transcranial Direct Current Stimulation ◽  
Standard Treatment ◽  
Myofascial Pain ◽  
Pain Syndrome ◽  
Myofascial Pain Syndrome ◽  
Pain Reduction ◽  
Direct Current Stimulation

scholarly journals Transcranial Direct Current Stimulation of the Occipital Cortex in Medication Overuse Headache: A Pilot Randomized Controlled Cross-Over Study

2020 ◽  
Vol 9 (4) ◽  
pp. 1075 ◽  
Author(s):  
Anthony G. Mansour ◽  
Rechdi Ahdab ◽  
Georges Khazen ◽  
Christelle El-Khoury ◽  
Toni M. Sabbouh ◽  
...  
Keyword(s):  
Direct Current ◽  
Transcranial Direct Current Stimulation ◽  
Medication Overuse ◽  
Medication Overuse Headache ◽  
Pain Syndrome ◽  
Occipital Cortex ◽  
Daily Consumption ◽  
Direct Current Stimulation ◽  
Frequent Use ◽  
Age Range

Background: Medication overuse headache (MOH) is a chronic pain syndrome that arises from the frequent use of acute antimigraine drugs. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique with a possible therapeutic effect in this particular context. Methods: This was a randomized, sham-controlled, cross-over study. Eighteen patients with MOH (17 women, age range: 20–38 years) received three sets of three consecutive daily sessions of tDCS: anodal tDCS over the prefrontal cortex, cathodal tDCS over the occipital cortex ipsilateral to the dominant side of migraine pain, and sham. The order in which the tDCS blocks were delivered was randomly defined based on a 1:1:1 ratio. Patients filled in a migraine diary that allowed recording of the pain intensity (visual analogue scale) and the daily consumption of analgesic pills from one week before to two weeks after each condition. Results: Both prefrontal and occipital tDCS lowered the total number of migraine days and the number of severe migraine days per week at week 1, but only the effects of occipital tDCS on these two outcomes lasted until week 2. Only occipital tDCS decreased the daily analgesic pills consumption, at weeks 1 and 2. Conclusion: Three consecutive days of cathodal occipital tDCS appear to improve the clinical outcomes in patients with MOH.

scholarly journals Transcranial direct current stimulation (a-tCDS) after subacromial injections in patients with subacromial pain syndrome: a randomized controlled pilot study

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Samuel Larrivée ◽  
Frédéric Balg ◽  
Guillaume Léonard ◽  
Sonia Bédard ◽  
Michel Tousignant ◽  
...  
Keyword(s):  
Pilot Study ◽  
Direct Current ◽  
Transcranial Direct Current Stimulation ◽  
Repeated Measures ◽  
Symptomatic Relief ◽  
Pain Syndrome ◽  
Control Group ◽  
Significant Group ◽  
Direct Current Stimulation ◽  
Subacromial Pain Syndrome

Abstract Background Subacromial pain syndrome (SAPS) is a common complaint in orthopaedics. Subacromial corticosteroid injections (CSI) can relieve pain in the short term. Anodal transcranial direct current stimulation (a-tDCS) has been used for symptomatic pain relief in a variety of chronic pain conditions. The aim of this pilot study was to assess whether the application a-tDCS could enhance the symptomatic relief provided by CSI in patients affected by SAPS. Methods Thirty-eight participants (18 to 65-year-old) suffering from SAPS were recruited to have a CSI and randomly allocated to receive, 1 weeks post CSI, real a-tDCS (r-tDCS), sham tDCS (s-tDCS) or no intervention (Control). Upper limb function was measured 1 week prior to the CSI, at the 2- and 4-week follow-ups using self-administered questionnaires and physical measures. Self-reported pain and activity during each day were logged by the participants using visual analog scales (VAS). Differences between groups were tested using repeated-measures ANOVAs. Results Pain VAS and the Single Assessment Numeric Evaluation scale (SANE) showed significant improvement from baseline 2 weeks and 4 weeks after CSI in all groups (p < 0.05). There were no significant group X time interaction 2 weeks following tDCS treatment in any of the variables. Conclusion All groups showed significant improvement in pain VAS and SANE scores following the CSI. One session of a-tDCS treatment 2 weeks following CSI did not result in any additive or potentializing effects when compared to a s-tDCS or a control group. Trial registration ClinicalTrials.gov, NCT03967574. Registered 30 May 2019 - Retrospectively registered.

scholarly journals EFFECTIVENESS OF KINESIOLOGICAL TAPE IN MYOFASCIAL PAIN SYNDROME OF GASTROCNEMIUS MUSCLE

2021 ◽  
Vol 71 (5) ◽  
pp. 1666-68
Author(s):  
Riffat Asghar Gill ◽  
Muhammad Salman Bashir ◽  
Kehkshan Khalid ◽  
Naveed Anwar
Keyword(s):  
Gastrocnemius Muscle ◽  
Myofascial Pain ◽  
Sampling Technique ◽  
Pain Syndrome ◽  
Myofascial Pain Syndrome ◽  
Pain Reduction ◽  
Maximum Effect ◽  
Early Recovery ◽  
Reduction Of Pain ◽  
Quasi Experimental

Objective: To see the effectiveness of kinesiological tape in myofascial pain syndrome of gastrocnemius muscle for the early recovery after injury and thus increase functional outcome. Study Design: Quasi-experimental study. Place and Duration of Study: National cricket academy Lahore and Sports and Spine Professional’s Clinic, Defense Phase-IV Lahore Pakistan, from Aug 2017 to Oct 2017. Methodology: Consecutive sampling technique was used to enrol the patients of myofascial pain syndrome based on the predefined inclusion and exclusion criteria. Patients were selected and the kinesiological tape was applied thrice a week for two consecutive weeks. the patient was then re-evaluated after every two days of previous kinesiological tape application in terms of the visual Analogue Scale. Results: It was observed that kinesiological tape had a significant effect on pain reduction of the myofascial pain syndrome of the gastrocnemius muscle (p<0.001). There was a significant reduction of pain level after application of Kinesio tape till 4th application with pre-treatment means 6.70 ± 1.45 that was reduced to 2.98 ± 2.24 in post-treatment (p<0.05). In addition, there was no significant reduction of pain between the 5th and 6th application with mean for the 6th session as 2.96 ± 2.27 (p>0.05). Conclusion: The Kinesiological tape has a significant effect on pain reduction of gastrocnemius muscle suffering from myofascial pain syndrome. The application of kinesiological tape has maximum effect up to its 4th application. After 5th session of taping, the effect was almost constant. Keywords: ,  , , .

scholarly journals The Immediate Effect of Trigger Point Injection With Local Anesthetic Affects the Subsequent Course of Pain in Myofascial Pain Syndrome in Patients With Incurable Cancer by Setting Expectations as a Mediator

2021 ◽  
Vol 12 ◽  
Author(s):  
Hideaki Hasuo ◽  
Hiromichi Matsuoka ◽  
Yoshinobu Matsuda ◽  
Mikihiko Fukunaga
Keyword(s):  
Path Analysis ◽  
Local Anesthetic ◽  
Myofascial Pain ◽  
Trigger Point ◽  
Pain Syndrome ◽  
Myofascial Pain Syndrome ◽  
Pain Reduction ◽  
Single Center ◽  
Incurable Cancer ◽  
Point Injection

A trigger point injection (TPI) with local anesthetic in myofascial pain syndrome (MPS) often has the immediate effect of a decrease in pain. It is unknown whether the immediate effect of a decrease in pain affects the subsequent course of pain. It is also unknown whether expectations of a decrease in pain mediate such effects. We aimed to clarify how the effect of a decrease in pain immediately after TPI with local anesthetic affected the subsequent course of pain, and whether it increased expectations of a decrease in pain. This was a prospective, single-center, observational clinical trial. Patients with incurable cancer who visited the palliative care department and received TPI with local anesthetic for MPS were prospectively examined. We evaluated whether the immediate effect of a TPI with local anesthetic affects the subsequent course of pain in MPS by setting expectations as a mediator, using path analysis. From 2018 to 2020, 205 patients with incurable cancer received TPI for MPS. Of these, 58.1% of patients reported an immediate effect of decreased pain. Compared with the non-immediate effect group, the immediate effect group had higher expectations of a decrease in pain, and the higher expectation was maintained at 7 days (p &lt; 0.001). The percentage of patients with pain reduction at 7 days after TPI was 88.2% in the immediate effect group and 39.5% in the non-immediate effect group (p &lt; 0.001). The immediate effect of decreased pain had the greatest influence on pain reduction at 7 days, both directly (β = 0.194) and indirectly through increased expectations (β = 0.293), as revealed by path analysis. The effect of a decrease in pain immediately after TPI with local anesthetic affected the subsequent course of MPS pain in patients with incurable cancer by setting expectations as a mediator. There were limitations to the discussion of these findings because this was an observational study.

Sign in / Sign up

Export Citation Format

Share Document